Literature DB >> 17805461

Choline transporters in human lung adenocarcinoma: expression and functional implications.

Tao Wang1, Jinjun Li, Fei Chen, Yingjun Zhao, Xianghuo He, Dafang Wan, Jianren Gu.   

Abstract

Choline is an essential nutrient for cell survival and proliferation, however, the expression and function of choline transporters have not been well identified in cancer. In this study, we detected the mRNA and protein expression of organic cation transporter OCT3, carnitine/cation transporters OCTN1 and OCTN2, and choline transporter-like protein CTL1 in human lung adenocarcinoma cell lines A549, H1299 and SPC-A-1. Their expression pattern was further confirmed in 25 human primary adenocarcinoma tissues. The choline uptake in these cell lines was significantly blocked by CTL1 inhibitor, but only partially inhibited by OCT or OCTN inhibitors. The efficacy of these inhibitors on cell proliferation is closely correlated with their abilities to block choline transport. Under the native expression of these transporters, the total choline uptake was notably blocked by specific PI3K/AKT inhibitors. These results describe the expression of choline transporters and their relevant function in cell proliferation of human lung adenocarcinoma, thus providing a potential choline-starvation strategy of cancer interference through targeting choline transporters, especially CTL1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17805461     DOI: 10.1111/j.1745-7270.2007.00323.x

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  20 in total

Review 1.  Metabolic effects of signal transduction inhibition in cancer assessed by magnetic resonance spectroscopy.

Authors:  Siver Andreas Moestue; Olav Engebraaten; Ingrid Susann Gribbestad
Journal:  Mol Oncol       Date:  2011-04-23       Impact factor: 6.603

Review 2.  Choline transport for phospholipid synthesis: An emerging role of choline transporter-like protein 1.

Authors:  Vera Hedtke; Marica Bakovic
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-18

Review 3.  Choline metabolism in malignant transformation.

Authors:  Kristine Glunde; Zaver M Bhujwalla; Sabrina M Ronen
Journal:  Nat Rev Cancer       Date:  2011-11-17       Impact factor: 60.716

4.  Reduced dimethylaminoethanol in [(18)F]fluoromethylcholine: an important step towards enhanced tumour visualization.

Authors:  Dominique Slaets; Sylvie De Bruyne; Caroline Dumolyn; Lieselotte Moerman; Koen Mertens; Filip De Vos
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-06-18       Impact factor: 9.236

Review 5.  Non-neuronal cholinergic system in airways and lung cancer susceptibility.

Authors:  Laura Saracino; Michele Zorzetto; Simona Inghilleri; Ernesto Pozzi; Giulia Maria Stella
Journal:  Transl Lung Cancer Res       Date:  2013-08

Review 6.  Muscarinic receptor agonists and antagonists: effects on cancer.

Authors:  Eliot R Spindel
Journal:  Handb Exp Pharmacol       Date:  2012

Review 7.  Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.

Authors:  Sean P Arlauckas; Anatoliy V Popov; E James Delikatny
Journal:  Prog Lipid Res       Date:  2016-04-09       Impact factor: 16.195

8.  Influence of multidrug resistance on (18)F-FCH cellular uptake in a glioblastoma model.

Authors:  Claire Vanpouille; Nathalie Le Jeune; David Kryza; Anthony Clotagatide; Marc Janier; Francis Dubois; Nathalie Perek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-03-20       Impact factor: 9.236

9.  The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization.

Authors:  Fang-Yi Lo; Jer-Wei Chang; I-Shou Chang; Yann-Jang Chen; Han-Shui Hsu; Shiu-Feng Kathy Huang; Fang-Yu Tsai; Shih Sheng Jiang; Rajani Kanteti; Suvobroto Nandi; Ravi Salgia; Yi-Ching Wang
Journal:  BMC Cancer       Date:  2012-06-12       Impact factor: 4.430

10.  A choline derivate-modified nanoprobe for glioma diagnosis using MRI.

Authors:  Jianfeng Li; Shixian Huang; Kun Shao; Yang Liu; Sai An; Yuyang Kuang; Yubo Guo; Haojun Ma; Xuxia Wang; Chen Jiang
Journal:  Sci Rep       Date:  2013       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.